Skip to main content

Video Library

Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP
Videos
09/10/2025
Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, shares the development and expansion of a structured mentorship program for advanced practice providers and clinical research coordinators in a community oncology setting.
Christa Marie Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, shares the development and expansion of a structured mentorship program for advanced practice providers and clinical research coordinators in a community oncology setting.
Christa Marie Braun-Inglis, DNP,...
09/10/2025
APP Institute Oncology
Samantha Shenoy, NP, UCSF Health
Videos
08/12/2025
Samantha Shenoy, NP
Samantha Shenoy, NP, explains the treatment course of a patient diagnosed with kappa light chain myeloma and discusses key interventions when caring for a patient on BCMA-targeted bispecific antibody therapy.
Samantha Shenoy, NP, explains the treatment course of a patient diagnosed with kappa light chain myeloma and discusses key interventions when caring for a patient on BCMA-targeted bispecific antibody therapy.
Samantha Shenoy, NP, explains...
08/12/2025
APP Institute Oncology
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology
Beth Faiman & Donna Catamero
Clinical Pearls
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
APP Institute Oncology
Beth Faiman & Donna Catamero
Clinical Pearls
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
APP Institute Oncology
David Spigel, MD, Sarah Cannon Research Institute
Videos
06/16/2025
David Spigel, MD
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the...
06/16/2025
APP Institute Oncology
Rebecca Ganzon, MS, APRN-CNP, AOCNP, Ohio Health
Videos
06/05/2025
Rebecca Ganzon, MS, APRN-CNP, AOCNP
Rebecca Ganzon, MS, APRN-CNP, AOCNP, presents the case of a patient with gastrointestinal stromal tumor with a PDGFR-alpha D842V mutation (exon 18).
Rebecca Ganzon, MS, APRN-CNP, AOCNP, presents the case of a patient with gastrointestinal stromal tumor with a PDGFR-alpha D842V mutation (exon 18).
Rebecca Ganzon, MS, APRN-CNP,...
06/05/2025
APP Institute Oncology
Patrick Forde, MBBCh
Videos
06/05/2025
Patrick Forde, MD
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares...
06/05/2025
APP Institute Oncology
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
Videos
05/20/2025
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong...
05/20/2025
APP Institute Oncology